US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Niagen Bioscience

12.95

+1.4412.51%

Post-market: 13.010.0600+0.46%19:59 EDT

Volume:1.22M

Turnover:15.49M

Market Cap:1.02B

PE:72.36

High:13.12

Open:11.94

Low:11.82

Close:11.51

Loading ...

Overview Company News Filings

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

THOMSON REUTERS

Niagen Says Its Operations Remain Resilient Amid Recent Tariff Developments

MT Newswires Live

Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments

THOMSON REUTERS

Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments

Growth Companies With High Insider Ownership For April 2025

Simply Wall St.

Niagen Bioscience Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Simply Wall St.

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Niagen Bioscience broadens NAD+ precursor IP portfolio with new patent

Niagen Bioscience Gets US Composition of Matter Patent for Nicotinamide Riboside Salt Forms

MT Newswires Live

Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science

ChromaDex Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

BRIEF-Chromadex announces name change and new ticker symbol effective March 19

Chromadex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "Nage" Effective March 19, 2025

THOMSON REUTERS

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NAGE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":12.95,"timestamp":1749240000000,"preClose":11.51,"halted":0,"volume":1222598,"hourTrading":{"tag":"盘后","latestPrice":13.01,"preClose":12.95,"latestTime":"19:59 EDT","volume":11956,"amount":155390.6659,"timestamp":1749254371129},"delay":0,"floatShares":51581706,"shares":78936662,"eps":0.178968,"marketStatus":"Market Closed","change":1.44,"latestTime":"06-06 16:00:00 EDT","open":11.935,"high":13.115,"low":11.82,"amount":15487268.723186001,"amplitude":0.112511,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.178968,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":11.51,"preHourTrading":{"tag":"盘前","latestPrice":11.93,"preClose":11.51,"latestTime":"09:29 EDT","volume":3714,"amount":43907.323968000004,"timestamp":1749216583539},"postHourTrading":{"tag":"盘后","latestPrice":13.01,"preClose":12.95,"latestTime":"19:59 EDT","volume":11956,"amount":155390.6659,"timestamp":1749254371129},"volumeRatio":1.2674569705188112,"impliedVol":0.7167,"impliedVolPercentile":0.3393},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":51581706,"roa":"12.21%","roe":"33.47%","lyrEps":0.112605,"volumeRatio":1.2674569705188112,"shares":78936662,"dividePrice":0,"high":13.115,"amplitude":0.112511,"preClose":11.51,"low":11.82,"week52Low":2.305,"pbRate":"18.47","psRate":"9.47","week52High":13.115,"institutionHeld":0,"latestPrice":12.95,"eps":0.178968,"divideRate":0,"volume":1222598,"delay":0,"ttmEps":0.178968,"open":11.935,"prevYearClose":5.305,"prevWeekClose":10.82,"prevMonthClose":10.82,"prevQuarterClose":6.9,"fiveDayClose":10.82,"twentyDayClose":9.24,"sixtyDayClose":7.83},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525090886","title":"Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2525090886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525090886?lang=en_us&edition=fundamental","pubTime":"2025-04-08 10:32","pubTimestamp":1744079553,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QL0XB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2525704136","title":"Niagen Says Its Operations Remain Resilient Amid Recent Tariff Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2525704136","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525704136?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:59","pubTimestamp":1744034395,"startTime":"0","endTime":"0","summary":"Niagen Bioscience  said Monday that it does not expect global tariffs to disrupt its ability to manufacture food- and pharmaceutical-grade Niagen products, nor will they have an adverse impact on its ability to maintain costs and pricing.The company said all of its vitamins and food supplements are manufactured in the US by privately held specialty chemicals company WR Grace and are tested, bottled and packaged domestically. It also said only a small percentage of its raw materials are sourced internationally, which keeps costs relatively stable in the face of global price volatility.Foreign sales accounted for 24% of Niagen's revenue last year, with half of that coming from AS Watson in Hong Kong, which remains a duty-free market, the company said.Niagen chief executive officer Rob Fried said the company had previously decided to establish a US-based supply chain to ensure long-term resilience and quality.Niagen shares were more than 6% lower soon after Monday's opening bell.Price: 5.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"2525010753","title":"Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2525010753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525010753?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:32","pubTimestamp":1744029129,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL05F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NAGE"],"gpt_icon":0},{"id":"2525704853","title":"Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2525704853","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525704853?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:32","pubTimestamp":1744029120,"startTime":"0","endTime":"0","summary":"The Company’s flagship patented nicotinamide riboside  ingredient, Niagen, is manufactured, encapsulated, and bottled in the U.S. and is currently classified as exempt from tariffs, minimizing exposure to tariff-related risks. LOS ANGELES, April 07, 2025----Niagen Bioscience, Inc.  , the global authority on NAD+  with a focus on the science of healthy aging, reaffirms that the manufacturing of its Niagen ingredient  and Tru Niagen and pharmaceutical-grade Niagen products remain resilient amid the recently enacted global tariffs.Manufactured in the U.S. by the Company’s partner, W.R. Grace, Niagen is rigorously tested, encapsulated, bottled, and packaged domestically as Tru Niagen using premium materials. With only a small percentage of materials sourced internationally, the cost to manufacture final Niagen products remains largely insulated from global price volatility.\"We made the decision to build a U.S.-based supply chain for Niagen to safeguard long-term resilience, trust, and qual","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/niagen-bioscience-confirms-operations-remain-123200897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2524961892","title":"Growth Companies With High Insider Ownership For April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524961892","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524961892?lang=en_us&edition=fundamental","pubTime":"2025-04-04 01:06","pubTimestamp":1743699986,"startTime":"0","endTime":"0","summary":"As the U.S. market grapples with the impact of newly announced tariffs, resulting in a sharp decline across major indices like the Dow Jones and Nasdaq, investors are increasingly focused on how these measures might affect economic growth and corporate profits. In such volatile conditions, companies with strong insider ownership often attract attention as they can indicate confidence from those who know the business best; this article highlights three growth companies in the United States where insiders hold significant stakes.Top 10 Growth Companies With High Insider Ownership In The United States. Delve into the full analysis future growth report here for a deeper understanding of Niagen Bioscience.Our comprehensive valuation report raises the possibility that Niagen Bioscience is priced higher than what may be justified by its financials.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/growth-companies-high-insider-ownership-170626368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BK4023","BK4539","EXFY","NAGE","BK4113","BK4129","TBBB","BWMN"],"gpt_icon":1},{"id":"2523910198","title":"Niagen Bioscience Price Target Maintained With a $11.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910198?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:23","pubTimestamp":1743420180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 07:23 ET (11:23 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"gpt_icon":0},{"id":"2523661120","title":"A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523661120","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523661120?lang=en_us&edition=fundamental","pubTime":"2025-03-29 21:53","pubTimestamp":1743256394,"startTime":"0","endTime":"0","summary":"Key Insights Niagen Bioscience's estimated fair value is US$7.18 based on 2 Stage Free Cash Flow to Equity Niagen...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nage/niagen-bioscience/news/a-look-at-the-fair-value-of-niagen-bioscience-inc-nasdaqnage","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","NVIW.SI","TSYW.SI","USJW.SI","NAGE","IE00BGHQF748.EUR","QID","LU2095319765.USD","SQQQ","BK4588","FCF","BK4211","QLD","DCF","TQQQ","BK4100","MNQmain","IE00BKPKM429.USD","BK4112","BK4585","LU2210150020.SGD","USAW.SI","IE00B64PRP62.GBP","NQmain","IE00B3QW5Z07.USD","NDAQ",".IXIC","PSQ","TV","LU2210149790.SGD"],"gpt_icon":1},{"id":"2522721970","title":"Why ChromaDex Corp (CDXC) Is Surging In 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522721970","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522721970?lang=en_us&edition=fundamental","pubTime":"2025-03-25 21:22","pubTimestamp":1742908976,"startTime":"0","endTime":"0","summary":"We recently published a list of Why These 15 Defensive Stocks Are Surging In 2025. In this article, we are going to take a look at where ChromaDex Corp  stands against other defensive stocks that are surging in 2025.Defensive stocks are surging as investors have been shifting their focus. Growth stocks dominated the past two years. Now, slower economic signals and rising risks are changing the landscape due to market uncertainty.Defensive stocks offer much more stability and tend to perform well even in tough times. People still need electricity, medicine, and food. That reliability draws investors when uncertainty grows.Many are rotating into these stocks for safety. The surge suggests a broader trend. It could mark a turning point after years of growth-led rallies., so it’s worth looking into the defensive stocks that stand out right now.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-chromadex-corp-cdxc-surging-132256859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAGE","QLD","NVIW.SI","TSYW.SI",".IXIC","USAW.SI","TQQQ","USJW.SI","PSQ","BK4121","MNQmain","NQmain","SQQQ","QID"],"gpt_icon":1},{"id":"2521146091","title":"Niagen Bioscience broadens NAD+ precursor IP portfolio with new patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2521146091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521146091?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:05","pubTimestamp":1742493941,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) formerly ChromaDex Corp announced the broadening of its NAD+ precursor intellectual property or IP portfolio with the newl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-broadens-nad-precursor-ip-portfolio-with-new-patent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-broadens-nad-precursor-ip-portfolio-with-new-patent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2463526074.USD","NAD","BK4136","IP","BK4588","LU1481600234.SGD","NAGE","LU1487256676.USD","LU1481599808.USD"],"gpt_icon":0},{"id":"2520023454","title":"Niagen Bioscience Gets US Composition of Matter Patent for Nicotinamide Riboside Salt Forms","url":"https://stock-news.laohu8.com/highlight/detail?id=2520023454","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520023454?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:37","pubTimestamp":1742477832,"startTime":"0","endTime":"0","summary":"Niagen Bioscience  said Thursday that it has received a US patent for composition of matter for nicotinamide riboside salt forms, expanding its nicotinamide adenine dinucleotide precursor intellectual property portfolio.The company said it owns and licenses a portfolio of more than 90 patents related to its nicotinamide riboside ingredient Niagen.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAGE"],"gpt_icon":0},{"id":"2520456087","title":"Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms","url":"https://stock-news.laohu8.com/highlight/detail?id=2520456087","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520456087?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:34","pubTimestamp":1742474040,"startTime":"0","endTime":"0","summary":"Exclusively licensed from Queen’s University Belfast , this composition of matter patent, one of the most robust forms of intellectual property protection, grants Niagen Bioscience exclusive rights to various salt forms of NR and derivatives. LOS ANGELES, March 20, 2025----Niagen Bioscience, Inc.  , the global authority on NAD+  with a focus on the science of healthy aging, today announced the broadening of its NAD+ precursor intellectual property  portfolio with the newly granted U.S. Patent 12,252,506, which covers the composition of matter for nicotinamide riboside  salt forms, including NR Malate and NR Tartrate, and other NR derivatives. This is part of a family of patents covering methods of making NR and related derivatives, some of the most efficient NAD+ precursors available, which Niagen Bioscience has through an exclusive license from Queen’s University Belfast .Niagen Bioscience, Inc. , formerly ChromaDex Corp., is the global leader in NAD+ (nico","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/niagen-bioscience-secures-u-patent-123400908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4136","LU1487256676.USD","BK4588","IP","NAGE","LU1481599808.USD","BK4585","LU1481600234.SGD","LU2463526074.USD"],"gpt_icon":0},{"id":"2520154203","title":"ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science","url":"https://stock-news.laohu8.com/highlight/detail?id=2520154203","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520154203?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:34","pubTimestamp":1742387640,"startTime":"0","endTime":"0","summary":"Rob Fried, CEO of Niagen Bioscience, on this milestone moment. Niagen Bioscience’s state-of-the-art research and development facility in Longmont, CO, which serves as the hub for the Company’s gold-standard quality practices. The rebrand celebrates the company’s clinically proven flagship patented nicotinamide riboside  ingredient, Niagen, the most well-researched, efficient, high-quality, and legal NAD+ booster available. \"This is more than a name change; this is a turning point in our story,\" said Rob Fried, CEO of Niagen Bioscience. \"We have achieved several scientific, financial, and strategic milestones. As Niagen Bioscience, the global leader in NAD+ science and commerce, we have the opportunity to help every living being around the world age better.\". Building on a 25+ year legacy, Niagen Bioscience’s renewed mission is simple yet powerful: \"There’s a better way to age.\" The Company remains dedicated to addressing one of life’s most complex challenges—aging. Embodying precision ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chromadex-evolves-niagen-bioscience-marking-123400733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAD","NAGE"],"gpt_icon":0},{"id":"2520754156","title":"ChromaDex Price Target Maintained With a $11.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520754156","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520754156?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:08","pubTimestamp":1742209680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CDXC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 07:08 ET (11:08 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDXC","NAGE"],"gpt_icon":0},{"id":"2519085825","title":"BRIEF-Chromadex announces name change and new ticker symbol effective March 19","url":"https://stock-news.laohu8.com/highlight/detail?id=2519085825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519085825?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:43","pubTimestamp":1741876986,"startTime":"0","endTime":"0","summary":"BRIEF-Chromadex announces name change and new ticker symbol effective March 19March 13 (Reuters) - Chromadex Corp CDXC.O:CHROMADEX CORP. ANNOUNCES NAME CHANGE TO NIAGEN BIOSCIENCE, INC. AND NEW TICKER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW0ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","CDXC"],"gpt_icon":0},{"id":"2519083671","title":"Chromadex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol \"Nage\" Effective March 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519083671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519083671?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:34","pubTimestamp":1741869249,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nFWN3PW0ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDXC","NAGE"],"gpt_icon":0},{"id":"2519839311","title":"ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol \"NAGE\" Effective March 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519839311","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519839311?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:34","pubTimestamp":1741869240,"startTime":"0","endTime":"0","summary":"LOS ANGELES, March 13, 2025----ChromaDex Corp. , the global authority on NAD+  with a focus on the science of healthy aging, today announced that it will change its corporate name to Niagen Bioscience, Inc. and trade under the new Nasdaq symbol \"NAGE\" effective at stock market open on Wednesday, March 19, 2025.As part of this transition, the Company will deploy a follow-up announcement with additional updates regarding the name change, rebrand, and future initiatives.No action is required by existing shareholders with respect to the ticker symbol change. The Company’s common stock will continue to be listed on Nasdaq and the CUSIP will remain unchanged.This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chromadex-corp-announces-name-change-123400865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","MNQmain","CDXC","QLD",".IXIC","TSYW.SI","BK4121","PSQ","USJW.SI","TQQQ","NAGE","SQQQ","NVIW.SI","NQmain","QID"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"NAGE","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-03-04","symbol":"NAGE","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2024-10-31","symbol":"NAGE","fiscalQuarterEnding":"2024/09","expectedEps":0.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":0.02},{"market":"US","date":"2024-08-07","symbol":"NAGE","fiscalQuarterEnding":"2024/06","expectedEps":-0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2024-05-08","symbol":"NAGE","fiscalQuarterEnding":"2024/03","expectedEps":-0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1748404800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2025-06-06","current":64.414107,"percent":0.592593,"low":49.393282,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"high":80.324484,"avg":62.549674,"sd":7.235851,"marketCap":908560979},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979}],"updateTime":1749346634841}}}